TISSUE-PLASMINOGEN ACTIVATOR FOR HEPATIC VEIN-THROMBOSIS IN PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA

Paroxysmal nocturnal haemoglobinuria (PNH) is an acquired clonal disorder thought to arise in a murtipotent haemopoietic stem cell. A distinct clinical feature is a tendency to thrombosis, with a particular predilection for the hepatic veins (Budd-Chiari syndrome). We report here on two patients with PNH who developed hepatic vein thrombosis (HVT) and who were treated with tissue plasminogen activator (t-PA). Both patients had a marked clinical and radiological improvement following the t-PA treatment and remain well over 2 years and 6 years after the treatment. This method of thrombolysis for HVT occurring in PNH has only been reported in two previous patients with limited follow-up. We suggest that this therapy is a useful first-line treatment for PNH patients who develop HVT.